CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 178 enrolled
Drug / intervention
aspirindrug
Likely dose
aspirin 100 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01353144
NCT01353144Phase 4Completed
CompareCT.gov

A Comparison of Two Therapeutic Strategies for the Treatment of Aspirin-associated Peptic Ulcers

Kaohsiung Veterans General Hospital.·interventional·Posted May 12, 2011·Updated Nov 1, 2016

In Brief

A Phase 4 clinical trial evaluating aspirin for Peptic Ulcer. Completed, enrolled 178 participants across 3 sites.

Detailed Summary

Esomeprazole plus aspirin compared with esomeprazole alone for the treatment of aspirin-related peptic ulcers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeptic Ulcer
CountriesTaiwan
Collaborators--

Timeline

Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 12, 2011
Enrollment StartJun 1, 2007
Primary CompletionMay 1, 2008
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 15.1 years ago

Interventions

aspirindrug

aspirin, 100 mg, qd x 8 weeks